VigNet Incorporated

VigNet Incorporated has been granted 111 US utility patents between 2017 and 2025, placing VigNet Incorporated at rank #3,363 across all assignees tracked by PlainPatent. This portfolio spans 14 distinct Cooperative Patent Classification (CPC) subclasses, averaging 21.9 claims per patent with primary concentration in G16H (HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA). As a US Corporation, VigNet Incorporated is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 58.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 103 grants, compared with 8 in the 2015–2019 window — a +1188% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. VigNet Incorporated's 21.9 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 14 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark VigNet Incorporated against peers pursuing similar technology classes.